I think today's rapid increase has something to do with InterMune (ITMN); it is up over 150% on the release of Phase 3 trial results. Elite is close to releasing its own results as well, so maybe some positive effects from the biotech industry. Hopefully we continue up this week and get patent news release early next week. That should set us up nicely for the following week when our trial results are released. What to expect the week after that, news on a partner? I see over $1 on our trial results, over $2 on a partner.